Facebook
Twitter
LinkedIn
ForwardSession Description:
Neuro-oncology tumor board conferences allow neurosurgeons, medical and radiation oncologists, and other oncology professionals to present patient cases in order to educate attendees on new surgical procedures or treatments and receive a consensus of recommendations for treatment. New procedures or journal articles are discussed as well as clinical trial patients may be eligible to enroll in.
Target Audience:
Physicians (MD or DO)
Other Healthcare Professionals
Learning Objectives:
Upon completion of this learning activity, participants should be able to:
1. Discuss the process for time-sensitive enrollment into open clinical trials for newly diagnosed, or recurrent, brain cancer patients.
2. Review, analyze, and discuss current peer reviewed journal articles on topics relevant to neuro-oncology with the goal of improving quality of care for patients.
3. Demonstrate cultural humility in interactions with families of diverse cultures and belief systems that influence how they perceive health and illness and respond to neuro-oncology diseases, symptoms and treatments.
4. Utilize evidence-based medicine to identify care and treatment options for optimal treatment of complex and unusual neuro-oncology disease presentations.
Providing Culturally Appropriate Care which is Free of Implicit Biases (AB 1195 & 241):
Learners are strongly encouraged to engage in self-directed learning related to the impact of implicit biases in this clinical area via the references provided below:
Fiscella, K., Epstein, R. M., Griggs, J. J., Marshall, M. M., & Shields, C. G. (2021). Is physician implicit bias associated with differences in care by patient race for metastatic cancer-related pain? PLOS ONE, 16(10), e0257794. https://doi.org/10.1371/journal.pone.0257794
Smith, J., Johnson, A., & Lee, R. (2024). Best practices for addressing the health needs of the LGBTQ+ community in oncology care. Journal of Oncology Practice, 20(4), 123-135. https://doi.org/10.1200/JOP.2024.123456
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
No one involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Live activity was designated for a maximum of 1.00 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.